[HTML][HTML] Forest volatile organic compounds and their effects on human health: A state-of-the-art review
The aim of this research work is to analyze the chemistry and diversity of forest VOCs
(volatile organic compounds) and to outline their evidence-based effects on health. This …
(volatile organic compounds) and to outline their evidence-based effects on health. This …
[HTML][HTML] The CB2 receptor and its role as a regulator of inflammation
C Turcotte, MR Blanchet, M Laviolette… - Cellular and Molecular …, 2016 - Springer
The CB 2 receptor is the peripheral receptor for cannabinoids. It is mainly expressed in
immune tissues, highlighting the possibility that the endocannabinoid system has an …
immune tissues, highlighting the possibility that the endocannabinoid system has an …
[HTML][HTML] Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Mucosal healing plays a critical role in combatting the effects of inflammatory bowel disease,
fistulae and ulcers. While most treatments for such diseases focus on systemically delivered …
fistulae and ulcers. While most treatments for such diseases focus on systemically delivered …
[HTML][HTML] Therapeutic potential of volatile terpenes and terpenoids from forests for inflammatory diseases
Forest trees are a major source of biogenic volatile organic compounds (BVOCs). Terpenes
and terpenoids are known as the main BVOCs of forest aerosols. These compounds have …
and terpenoids are known as the main BVOCs of forest aerosols. These compounds have …
Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and …
EP Baron - Headache: The Journal of Head and Face Pain, 2018 - Wiley Online Library
Background Comprehensive literature reviews of historical perspectives and evidence
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …
Cannabis pharmacology: the usual suspects and a few promising leads
EB Russo, J Marcu - Advances in pharmacology, 2017 - Elsevier
The golden age of cannabis pharmacology began in the 1960s as Raphael Mechoulam and
his colleagues in Israel isolated and synthesized cannabidiol, tetrahydrocannabinol, and …
his colleagues in Israel isolated and synthesized cannabidiol, tetrahydrocannabinol, and …
Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
This review article focuses on pre-clinical and clinical studies with some selected Brazilian
medicinal plants in different areas of interest, conducted by research groups in Brazil and …
medicinal plants in different areas of interest, conducted by research groups in Brazil and …
[HTML][HTML] Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation
R Scandiffio, F Geddo, E Cottone, G Querio… - Nutrients, 2020 - mdpi.com
(E)-β-caryophyllene (BCP) is a bicyclic sesquiterpene widely distributed in the plant
kingdom, where it contributes a unique aroma to essential oils and has a pivotal role in the …
kingdom, where it contributes a unique aroma to essential oils and has a pivotal role in the …
Biomaterials coating for on-demand bacteria delivery: Selective release, adhesion, and detachment
Bacteria-based therapy has shown great promise in treating various diseases by regulating
intestinal flora balance in pre-clinical and clinical studies. However, weak resistance against …
intestinal flora balance in pre-clinical and clinical studies. However, weak resistance against …
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
A Bahi, S Al Mansouri, E Al Memari, M Al Ameri… - Physiology & …, 2014 - Elsevier
Recent evidence suggests that the cannabinoid receptor subtype 2 (CB 2) is implicated in
anxiety and depression disorders, although few systematic studies in laboratory animals …
anxiety and depression disorders, although few systematic studies in laboratory animals …